DexCom (DXCM) faces GLP-1 disruption as it targets non-insulin Type 2 CGM growth. Read here for a detailed invesment analysis ...

Parents of young children with elevated blood sugar now have a new option that does not require a doctor’s prescription. The ...

Tandem Diabetes Care has announced that its t X2 insulin pump with Control-IQ+ automated insulin delivery technology is now compatible with Abbott’s FreeStyle Libre 3 Plus continuous glucose monitorin ...

AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...

Compare the best Samsung Watch CGM apps and Wear OS tools for blood sugar readings, including Dexcom G6, Gluroo, and xDrip+.

Dexcom is transforming its Stelo CGM into a whole-family wellness device, securing FDA clearance for pediatric use and debuting new AI tools.

Insulet (PODD) stock and DexCom (DXCM) receive new Buy ratings from Deutsche Bank while Tandem Diabetes Care (TNDM) stock ...

A non-prescription continuous glucose monitor has been cleared for use in pediatric patients aged 2 years and older with diabetes who do not use insulin. HealthDay News — The U.S. Food and Drug ...

Ultrahuman has expanded its digital health ecosystem with the US launch of M2 Live, an updated metabolic health platform that integrates continuous glucose data from Abbott’s over-the-counter Lingo ...

Over-the-counter continuous glucose monitors have gained popularity over recent years. These devices are designed to help people manage diabetes and other conditions that require monitoring of their ...

FDA clears Dexcom Stelo as the first OTC CGM for children, raising new questions around app access, caregiver oversight, ...

DexCom's FDA-cleared Stelo OTC glucose biosensor now covers children aged above 2 years not using insulin, expanding access to smartphone-linked CGM insights.